BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12149148)

  • 21. Treatment with the Chk1 inhibitor Gö6976 enhances cisplatin cytotoxicity in SCLC cells.
    Thompson R; Meuth M; Woll P; Zhu Y; Danson S
    Int J Oncol; 2012 Jan; 40(1):194-202. PubMed ID: 21894433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity.
    Awasthi S; Singhal SS; Singhal J; Yang Y; Zimniak P; Awasthi YC
    Int J Oncol; 2003 Apr; 22(4):721-32. PubMed ID: 12632061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J; Ko HS; Sohn EJ; Kim B; Kim JH; Kim HJ; Kim C; Kim JE; Kim SH
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1188-91. PubMed ID: 24461294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.
    Mizutani Y; Wu XX; Yoshida O; Shirasaka T; Bonavida B
    Oncol Rep; 1999; 6(5):979-82. PubMed ID: 10425290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
    Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
    Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells.
    Horwacik I; Durbas M; Boratyn E; Węgrzyn P; Rokita H
    Cancer Lett; 2013 Dec; 341(2):248-64. PubMed ID: 23962557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
    Li J; Viallet J; Haura EB
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):525-34. PubMed ID: 17505826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of roles of three mitogen-activated protein kinases induced by chromium(VI) and cadmium in non-small-cell lung carcinoma cells.
    Chuang SM; Yang JL
    Mol Cell Biochem; 2001 Jun; 222(1-2):85-95. PubMed ID: 11678615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.
    Kim R; Ohi Y; Inoue H; Toge T
    Anticancer Res; 2000; 20(1A):439-44. PubMed ID: 10769693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling and function of caspase and c-jun N-terminal kinase in cisplatin-induced apoptosis.
    Koo MS; Kwo YG; Park JH; Choi WJ; Billiar TR; Kim YM
    Mol Cells; 2002 Apr; 13(2):194-201. PubMed ID: 12018840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.
    Xu L; Fu Y; Li Y; Han X
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):235-242. PubMed ID: 28597042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
    Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells.
    Zhang H; Shi X; Zhang QJ; Hampong M; Paddon H; Wahyuningsih D; Pelech S
    J Biol Chem; 2002 Nov; 277(46):43648-58. PubMed ID: 12221076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin A receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells.
    Liu B; Wu Y; Zhou Y; Peng D
    PLoS One; 2014; 9(4):e93576. PubMed ID: 24727660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines.
    Fujita M; Tsuchida T; Higashino K
    Anticancer Drugs; 1999 Jan; 10(1):119-27. PubMed ID: 10194555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
    Cheresh DA; Rosenberg J; Mujoo K; Hirschowitz L; Reisfeld RA
    Cancer Res; 1986 Oct; 46(10):5112-8. PubMed ID: 3019521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flavopiridol potently induces small cell lung cancer apoptosis during S phase in a manner that involves early mitochondrial dysfunction.
    Litz J; Carlson P; Warshamana-Greene GS; Grant S; Krystal GW
    Clin Cancer Res; 2003 Oct; 9(12):4586-94. PubMed ID: 14555534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.